LGALS9 and nonpapillary renal cell carcinoma: We found that the genotype distribution of LGALS9 rs4794976 differed significantly between ccRCC patients and controls (p = 0.049), where the GG genotype individuals had a higher risk of disease, by about two-fold (OR = 1.91; 95% CI 1.13–3.22), compared to TT individuals.